Cytochalasins are cytoskeleton disrupters, and cytochalasin E has been repo
rted to increase intestinal paracellular permeability. In this study, the c
ytochalasin E effect on galactose transport has been investigated. Ussing-t
ype chamber experiments show an inhibitory effect of 20 mu M cytochalasin E
on unidirectional mucosal to serosal flux of galactose. On the contrary, t
he opposite unidirectional flux is not modified by the inhibitor. Results u
sing intestinal everted sacs and rings confirm that galactose uptake by the
tissue is diminished by cytochalasin E. The effect appears already after 5
min incubation, depends on cytochalasin E concentration, and does not occu
r in the absence of Na+. The inhibition is accompanied by an increase in th
e apparent K-m of the active sugar transport (11.5 vs.15.8 mM) without sign
ificant change in the V-max (10.6 vs. 9.1 mu mol.g(-1) wet weight.5 min(-1)
). Cytochalasin E does not modify either galactose uptake by brush border m
embrane vesicles or Na+-K+ ATPase activity in the enterocytes, indicating t
hat the inhibitory effect on the Na+-dependent sugar transport cannot be ex
plained as a direct effect on SGLT1 activity or as an indirect effect throu
gh the Na+-K+ ATPase. Thus, our results suggest that cytochalasin E decreas
es SGLT1 activity indirectly through cytoskeleton disruption.